Impact of Race on Use of Disease-Modifying Therapy in Multiple Sclerosis

Impact of Race on Use of Disease-Modifying Therapy in Multiple Sclerosis

Bibliographic Details
Main Author:	Hyland, Megan H.
Language:	English
Published:	Case Western Reserve University School of Graduate Studies / OhioLINK 2013
Subjects:	Medicine Neurology Multiple sclerosis Treatment Race
Online Access:	http://rave.ohiolink.edu/etdc/view?acc_num=case1355951207

Similar Items

Adherence to disease-modifying therapies in patients with multiple sclerosis
by: Kołtuniuk A, et al.
Published: (2018-08-01)

Multiple sclerosis and pregnancy- treatment considerations
by: Maciej Piotr Kamieniak, et al.
Published: (2020-12-01)

Multiple sclerosis and pregnancy. Impact of multiple sclerosis disease-modifying therapy on the health of newborns
by: T. I. Yakushina
Published: (2021-02-01)

Relapsing-remitting multiple sclerosis: advances in disease-modifying therapies
by: Kay, Kathleen Alexandra
Published: (2016)

The Prevalence of Alternative-complementary Therapies in Patients with Multiple Sclerosis
by: Rabia Gökçen Gözübatık Çelik, et al.
Published: (2019-09-01)

Current Advances in Pediatric Onset Multiple Sclerosis
by: Kristen S. Fisher, et al.
Published: (2020-03-01)

Multiple Sclerosis and Cancer: The Ying-Yang Effect of Disease Modifying Therapies
by: Esther Melamed, et al.
Published: (2020-01-01)

Symptomatic management in multiple sclerosis
by: Pushkar Shah
Published: (2015-01-01)

Co-Occurrence of Guillain-Barre Syndrome and Multiple Sclerosis: A Rare Case Report
by: Amr Hassan, et al.
Published: (2021-01-01)

Monogenic Diseases Masquerading as Multiple Sclerosis: A Systematic Review
by: Marino, Meghan J.
Published: (2011)

From Charcot’s descriptions to the current understanding of neuropsychiatric symptoms in multiple sclerosis
by: Carlos B. TAUIL, et al.

Therapeutic value of serum uric acid levels increasing in the treatment of multiple sclerosis
by: Tončev Goran
Published: (2006-01-01)

Complementary Therapy in Patients with Multiple Sclerosis
by: Payamani F, et al.
Published: (2012-08-01)

Time course of changes in the development of gait disorders in multiple sclerosis
by: A. M. Petrov, et al.
Published: (2015-03-01)

Prevalence of antinuclear antibody in patients with multiple sclerosis: a case-control study
by: Hind Alnajashi, et al.
Published: (2021-02-01)

Dynamic Responses of Microglia in Animal Models of Multiple Sclerosis
by: Melanie J. Plastini, et al.
Published: (2020-08-01)

Impact of depression on multiple sclerosis patients
by: Leonavičius Rytis, et al.
Published: (2012-10-01)

Multiple sclerosis: disease modifying therapy and the human leukocyte antigen
by: Lineu Cesar Werneck, et al.

A Personalized Approach in Progressive Multiple Sclerosis: The Current Status of Disease Modifying Therapies (DMTs) and Future Perspectives
by: Emanuele D’Amico, et al.
Published: (2016-10-01)

Physiotherapy in multiple sclerosis
by: Anna Łuszczyńska, et al.
Published: (2015-10-01)

Influence of Pregnancy in Multiple Sclerosis and Impact of Disease-Modifying Therapies
by: Isabella Laura Simone, et al.
Published: (2021-07-01)

Sarcoidosis and multiple sclerosis: systemic toxicity associated with the use of interferon-beta therapy
by: C. Carbonelli, et al.
Published: (2015-12-01)

The use of immunomodulatory therapy in pregnant patients with multiple sclerosis
by: Julia Rudnicka-Czerwiec, et al.
Published: (2018-11-01)

Clinical features in adult multiple sclerosis patients
by: Matej Koprivnik, et al.
Published: (2020-06-01)

State of the Art and Future Challenges in Multiple Sclerosis Research and Medical Management: An Insight into the 5th International Porto Congress of Multiple Sclerosis
by: María José Sá, et al.
Published: (2020-07-01)

Uveitis Related with Multiple Sclerosis
by: Sirel Gür Güngör, et al.
Published: (2012-12-01)

Therapeutic Approaches to Insomnia and Fatigue in Patients with Multiple Sclerosis
by: Drerup M, et al.
Published: (2021-02-01)

Perspectives and experiences of Dutch multiple sclerosis patients and multiple sclerosis-specialized neurologists on injectable disease-modifying treatment
by: Visser LH, et al.
Published: (2016-04-01)

The Effects of Multiple Sclerosis and Disease Modifying Therapy on Pregnancy
by: Tarneer Kaur Johal
Published: (2017-12-01)

Multiple Sclerosis: Methods of Treatment and Rehabilitation
by: Yuriy Lysenko
Published: (2017-06-01)

Multiple Sclerosis, Disease-Modifying Therapies and COVID-19: A Systematic Review on Immune Response and Vaccination Recommendations
by: Verónica Cabreira, et al.
Published: (2021-07-01)

Psychosocial predictors of patient adherence to disease-modifying therapies for multiple sclerosis
by: Alosaimi FD, et al.
Published: (2017-03-01)

PHYSICAL REHABILITATION AND LIFE QUALITY IN MULTIPLE SCLEROSIS
by: Ioan Buraga, et al.
Published: (2009-12-01)

General Principles of Treatment of Multiple Sclerosis in Children
by: Shorobura M.
Published: (2014-12-01)

Safety of Newer Disease Modifying Therapies in Multiple Sclerosis
by: Georges Jalkh, et al.
Published: (2021-12-01)

The Effectiveness of Neurological Music Intervention on Psychological Well-Being of Women With Multiple Sclerosis
by: Farahnaz Noormohammadi, et al.
Published: (2019-04-01)

Non-adherence to Disease-Modifying Treatments in Patients with Multiple Sclerosis
by: Seyed-Ali Roudbary, et al.
Published: (2017-08-01)

A multi-disciplinary approach towards elucidating the genetics of multiple sclerosis
by: De Villiers, J. N. P.
Published: (2012)

Multiple Sclerosis - From Bench to Bedside: Currents Insights into Pathophysiological Concepts and Their Potential Impact on Patients
Published: (2020)

Is It Time for Quotas to Achieve Racial and Ethnic Representation in Multiple Sclerosis Trials?
by: Farrah J. Mateen
Published: (2021-05-01)